Stay updated on Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The study has been updated to version v2.10.0, indicating a new revision, while the previous version v2.9.7 has been removed.
    Difference
    0.6%
    Check dated 2024-07-23T14:25:19.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T07:09:11.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-07-02T13:57:41.000Z thumbnail image
  8. Check
    30 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the version of the web page content.
    Difference
    0.1%
    Check dated 2024-06-27T09:56:49.000Z thumbnail image
  9. Check
    31 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-26T08:46:12.000Z thumbnail image
  10. Check
    32 days ago
    Change Detected
    Summary
    The value 'Show more Revision: v2.9.0' has been updated to 'MedlinePlus Genetics related topics: Head and neck squamous cell carcinoma. MedlinePlus related topics: Head and Neck Cancer. Drug Information available for: Nivolumab. FDA Drug and Device Resources'. This change indicates an update in the information related to the study, specifically highlighting the focus on genetics, cancer topics, and drug information.
    Difference
    15%
    Check dated 2024-06-25T08:22:56.000Z thumbnail image

Stay in the know with updates to Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial page.